Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
Maria Konoshenko, Yuriy Lansukhay, Sergey E. Krasilnikov, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7594-7594
Open Access | Times Cited: 18

Showing 18 citing articles:

Cisplatin in Liver Cancer Therapy
Sae Hamaya, Kyoko Oura, Asahiro Morishita, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10858-10858
Open Access | Times Cited: 38
PVT1 lncRNA in lung cancer: A key player in tumorigenesis and therapeutic opportunities
Mohammed Ageeli Hakami, Ali Hazazi, Farhan R. Khan, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155019-155019
Closed Access | Times Cited: 18
The Role of miRNAs in the Development, Proliferation, and Progression of Endometrial Cancer
Anna Bogaczyk, Izabela Zawlik, Tomasz Zuzak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11489-11489
Open Access | Times Cited: 9
Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers
Yang Shen, Nan Zhao, Nan Zhao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10823-10823
Open Access | Times Cited: 9
Integrated analysis reveals critical cisplatin-resistance regulators E2F7 contributed to tumor progression and metastasis in lung adenocarcinoma
Xiaomin Mao, Shumin Xu, Huan Wang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Combination of multiple omics techniques for a personalized therapy or treatment selection
Chiara Massa, Barbara Seliger
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Dipeptidase‑2 is a prognostic marker in lung adenocarcinoma that is correlated with its sensitivity to cisplatin
Yuanyi Wang, Ting Zhang, Hongfei Du, et al.
Oncology Reports (2023) Vol. 50, Iss. 2
Open Access | Times Cited: 2
Current landscape of miRNAs and TGF‐β signaling in lung cancer progression and therapeutic targets
Bashdar Mahmud Hussen, Safeen Jasim Saleem, Snur Rasool Abdullah, et al.
Molecular and Cellular Probes (2023) Vol. 72, pp. 101929-101929
Open Access | Times Cited: 2
Integrated analysis reveals critical cisplatin-resistance regulators E2F7 contributed to tumor progression and metastasis in lung adenocarcinoma
Xiaomin Mao, Shumin Xu, Huan Wang, et al.
Research Square (Research Square) (2024)
Open Access
TP53 mitigates cisplatin resistance in non-small cell lung cancer by mediating the effects of resistant cell-derived exosome mir-424-5p
Yan Deng, Hao Ding, Yanhua Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26853-e26853
Open Access
VGLL4 inhibits stemness and cisplatin resistance in non-small cell lung cancer via the COL3A1/NF-κB pathway

Journal of Men s Health (2024) Vol. 20, Iss. 6, pp. 129-129
Open Access
DNA hypomethylation of INHBA promotes tumor progression and predicts prognosis and immune status of gastric cancer
Xueying Li, Haizhong Jiang, Yangbo Fu, et al.
Hereditas (2024) Vol. 161, Iss. 1
Open Access
USP5‐dependent HDAC1 promotes cisplatin resistance and the malignant progression of non–small cell lung cancer by regulating RILP acetylation levels
Rongguo Lu, Yulin Jin, Mingfeng Zheng
Thoracic Cancer (2024)
Closed Access
Effects of the microRNA-99a-5p/VLDLR axis in lung cancer cell sensitivity to chemotherapy and its mechanism
Yaoguo Lang, Xianglong Kong, Benkun Liu, et al.
Brazilian Journal of Pharmaceutical Sciences (2023) Vol. 59
Open Access | Times Cited: 1
Diagnostic value of circulating miRNA in the benign and malignant lung nodules: A systematic review and meta-analysis
Li Liu, Fei Wang, Nan Yan, et al.
Medicine (2023) Vol. 102, Iss. 46, pp. e35857-e35857
Open Access | Times Cited: 1
Special Issue “miRNAs in the Era of Personalized Medicine: From Biomarkers to Therapeutics 2.0”
Bárbara Andrea Mc Cormack, Eva González-Cantó, Sarai Tomás-Pérez, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1951-1951
Open Access
Histone ubiquitination-related gene CUL4B promotes lung adenocarcinoma progression and cisplatin resistance
Yanjun Yin, Lifeng Zhang, Yinchuan Zeng, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access
THE ROLE OF miRNA IN CARCINOGENESIS
Adrianna NAWROT, Ewa Maciaszczyk‐Dziubinska
Postępy Biologii Komórki (2023) Vol. 50, Iss. 1, pp. 27-48
Open Access
Page 1

Scroll to top